3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with aptiganel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CR; Jung, DS; Kang, JK; McCulloch, J; Park, CK | 1 |
1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and aptiganel
| Article | Year |
|---|---|
Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction?
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Cerebral Infarction; Extracellular Space; Guanidines; Male; N-Methylaspartate; Piperazines; Rats; Rats, Sprague-Dawley | 1994 |